Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
kkolosov / Pixabay

Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients

BioSpace recently published a press release discussing the interim results highlighting a Coya Therapeutics’ study. The study evaluates the safety, tolerability, and biological activity of LD IL-2 in 38 patients…

Continue Reading Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
Could Simulated Sunshine Improve Psycho-Behavioral Symptoms in Alzheimer’s Disease?
Source: pixabay.com

Could Simulated Sunshine Improve Psycho-Behavioral Symptoms in Alzheimer’s Disease?

Alzheimer’s disease is a progressive neurodegenerative disease and the most common form of dementia. People with Alzheimer’s disease may have difficulty remembering information, problems with learning, sleep disruptions, poor judgment,…

Continue Reading Could Simulated Sunshine Improve Psycho-Behavioral Symptoms in Alzheimer’s Disease?
Does Brain Inflammation Play a Role in Alzheimer’s Disease?
source: shutterstock.com

Does Brain Inflammation Play a Role in Alzheimer’s Disease?

Neurogeneticist Michael Nalls of the US National Institute on Aging recently told Science Alert that a 2022 study, published in the Journal of Alzheimer’s Disease, completely changed their discovery approach.…

Continue Reading Does Brain Inflammation Play a Role in Alzheimer’s Disease?
Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
source: pixabay.com

Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death

Ferroptosis, a form of cell death, destroys microglia cells, which are associated with the brain’s immune system in vascular dementia and Alzheimer’s. Dr. Stephen Back suggested that attention had not…

Continue Reading Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
The NFL’s My Cause My Cleats 2023: Lacing Up for Awareness with Players’ Personal Stories 
Photo by Dave Adamson on Unsplash

The NFL’s My Cause My Cleats 2023: Lacing Up for Awareness with Players’ Personal Stories 

  During the NFL’s My Cause My Cleats initiative, passion and purpose collide on the field. This initiative embodies the profound bond between athletes and the causes that matter to…

Continue Reading The NFL’s My Cause My Cleats 2023: Lacing Up for Awareness with Players’ Personal Stories 
Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
source: shutterstock.com

Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science

  Roche has added another failure this year with its drug gantenerumab. As noted in Fierce Biotech, the drug was unable to improve functional or cognitive decline in two Phase…

Continue Reading Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
November was Alzheimer’s Awareness Month
source: pixabay.com

November was Alzheimer’s Awareness Month

  The need for increased awareness about Alzheimer’s disease is growing. The number of Alzheimer’s patients has increased since 1983, the year President Reagan designated November as Alzheimer’s Disease Awareness…

Continue Reading November was Alzheimer’s Awareness Month
New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
source: shutterstock.com

New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog

We are excited to announce that Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is…

Continue Reading New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals
source: pixabay.com

Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals

  Scientists have previously suggested that the gut microbiome plays a role in causing Alzheimer’s disease, and this has now been confirmed. A recent report from ScienceAlert covered a study…

Continue Reading Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals
Pseudobulbar Affect: Six Signs to Watch Out For
source: shutterstock.com

Pseudobulbar Affect: Six Signs to Watch Out For

Strokes, traumatic brain injuries, amyotrophic lateral sclerosis, Alzheimer's disease, and multiple sclerosis all share something in common: they all have profound effects on the brain and its function. They can…

Continue Reading Pseudobulbar Affect: Six Signs to Watch Out For
AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
source: pixabay.com

AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
A Preview of Potentially Historic FDA Approvals for 2023
source: shutterstock.com

A Preview of Potentially Historic FDA Approvals for 2023

  The later part of 2023 will see decisions on drugs in four areas such as advanced melanoma, sickle cell disease, Alzheimer’s disease, and depression. BioSpace shines the spotlight on…

Continue Reading A Preview of Potentially Historic FDA Approvals for 2023
FDA Panel Backs Approval of a New Drug for Alzheimer’s
source: pixabay.com

FDA Panel Backs Approval of a New Drug for Alzheimer’s

  The FDA advisory panel which is composed of specialists who advise the FDA on brain medications, recently voted 6-0 in agreement on that the new drug, Leqembi, was effective…

Continue Reading FDA Panel Backs Approval of a New Drug for Alzheimer’s
Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
source: pixabay.com

Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories

  The failure rate of drug development for Alzheimer’s is 99 percent according to a recent study. Since 1984 scientists have concentrated on developing treatments to prevent the formation of…

Continue Reading Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
Machine Learning Helps Identify Patterns of Progression in ALS
https://unsplash.com/photos/w7ZyuGYNpRQ

Machine Learning Helps Identify Patterns of Progression in ALS

According to a story from myscience.org, neurodegenerative diseases, such as amyotrophic lateral sclerosis, are diseases that progressively worsen over time. However, progression in this disease is not consistent across all…

Continue Reading Machine Learning Helps Identify Patterns of Progression in ALS
INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)
Source: Pixabay.com

INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)

From September to January each year, our home transforms; each Sunday, my boyfriend and I meticulously set up our living room, make snacks, and spend the day watching football on…

Continue Reading INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 1)